51ÂÜÀò

Degrees

  • Ph.D., University of California at Los Angeles.
  • B.S., University of California at Los Angeles.

Biography

Dr. Yohan Lee has led advanced technology organizations for over 20 years in commercial industry, education, and government. He has been privileged to serve as a civil scientist (U.S. National Institutes of Health), Principal Investigator (Google AI), Chief Science Officer (Riiid Labs, Inc.), and CEO (Scaled Entelechy, Inc). His undergraduate and doctoral studies were at UCLA in neuroscience and genomics with a focus on the neurological basis of learning and memory in addition to precision medicine. His doctoral work centered on large scale genomic data for health and distributed computing. In his corporate role, Dr. Lee has led research and business units in industry, public-private partnerships, the federal government, and international academic consortia for enterprise initiatives with Fortune 50 corporations. Most recently, Dr. Lee founded the Silicon Valley AI startup ‘Scaled Entelechy, Inc.’ which was recognized by the U.S. National Artificial Intelligence Initiative office for its AI applications to upskill the workforce in AI. Dr. Lee joins 51ÂÜÀò as the Promod and Doris Haque Endowed Chair of Technology and Associate Dean for the School of Science Technology and Health (SSTH). His hopes for the position are to drive the vision of SSTH to be identified among the world’s foremost Christ-centered STEM and health schools.

Awards

  • 2022 U.S. National Artificial Intelligence Initiative: 2ND Place. Feb 2023.
  • Google AI: Google Peer Recognition Award. Jan 2020.
  • Google AI: Google Peer Recognition Award. Oct 2019.
  • Google AI: Google Peer Recognition Award. May 2019.
  • Google AI: Google Peer Recognition Award. Mar 2019.
  • Newseum: Booz Allen Hamilton Rising Star Award. Jan 2018.
  • BMC Genomics: Top Cited Paper Award. 2008.

Publications

  • Perspectives for Securing Global Privacy in the Genomic Medicine Era, Health Law and Compliance UpdateLee Y., Byerley J., Kudszus N., Zaar S., Wolf D., Wolters Kluwer Law & Business, 2015.
    • Clinical utility of neuronal cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopathy, Kano S., Yuan M., Cardarelli R.A., Maegawa G., Higurashi N., Gaval-Cruz M., Wilson A.M., Tristan C., Kondo M.A., Chen Y., Koga M., Obie C., Ishizuka K., Seshadri S., Srivastava R., Kato T.A., Horiuchi Y., Sedlak T.W., Lee Y., Rapoport J.L., Hirose S., Okano H., Valle D., O'Donnell P., Sawa A., Kai M., Curr Mol Med, 2015.
    • Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity, Yoon K.J., Nguyen H.N., Ursini G., Zhang F., Kim N.S., Wen Z., Makri G., Nauen D., Shin J.H., Park Y., Chung R., Pekle E., Zhang C., Towe M., Hussaini S.M., Lee Y., Rujescu D., St Clair D., Kleinman J.E., Hyde T.M., Krauss G., Christian K.M., Rapoport J.L., Weinberger D.R., Song H., Ming G.L., Cell Stem Cell, 2014.

    Areas of Expertise for Media Interviews

    • Technology
    • Artificial Intelligence
    • Church
    • Computers
    • Education
    • Leadership
    • Neuroscience
    • Pharmacology
    • Spiritual Formation
    • Spiritual Warfare
    51ÂÜÀò
    13800 51ÂÜÀò Ave. La Mirada, CA 90639
    1-562-903-6000
    © 51ÂÜÀò, Inc. All Rights Reserved.